Kim, Kyung Min
Kim, A Ra
Lee, Wonwoo
Jang, Bo Hyun
Heo, Kyoung
Chu, Min Kyung
Funding for this research was provided by:
National Research Foundation of Korea (2019R1F1A1053841)
Article History
Received: 25 July 2021
Accepted: 18 April 2022
First Online: 29 April 2022
Competing interests
: MKC was a site investigator for a multi-center trial sponsored by Otsuka Korea, Novartis International AG, and Eli Lilly and Company. He worked as an advisory member for Teva and has received lecture honoraria from Allergan Korea, Handok-Teva, and Yuyu Pharmaceutical Company in the past 24 months. He received grants from Yonsei University College of Medicine (2018-32-0037) and National Research Foundation of Korea (2019R1F1A1053841). The other authors declare no conflicts of interest.